ID   C1R-B*27:05
AC   CVCL_C5VE
SY   C1R05
DR   PRIDE; PXD008500
DR   Wikidata; Q116048628
RX   PubMed=1692072;
RX   PubMed=25469497;
CC   Population: Caucasian.
CC   Transfected with: HGNC; 4932; HLA-B (allele B*27:05).
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3714 ! HMy2.C1R
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
RX   PubMed=1692072; DOI=10.4049/jimmunol.144.10.4038;
RA   Calvo V., Rojo S., Lopez D., Galocha B., Lopez de Castro J.A.;
RT   "Structure and diversity of HLA-B27-specific T cell epitopes. Analysis
RT   with site-directed mutants mimicking HLA-B27 subtype polymorphism.";
RL   J. Immunol. 144:4038-4045(1990).
//
RX   PubMed=25469497; DOI=10.1002/art.38980;
RA   Sanz-Bravo A., Campos J., Mazariegos M.S., Lopez de Castro J.A.;
RT   "Dominant role of the ERAP1 polymorphism R528K in shaping the HLA-B27
RT   peptidome through differential processing determined by multiple
RT   peptide residues.";
RL   Arthritis Rheumatol. 67:692-701(2015).
//